跳至主要内容
临床试验/NCT05947084
NCT05947084已完成不适用

Comparison of Growth and Tolerance of Healthy Term Infants Fed Iron-Fortified Infant Formulas. A 4 Month, Prospective, Randomized, Multi Center Clinical Trial.

Aussie Bubs, Inc.58 个研究点 分布在 1 个国家目标入组 518 人开始时间: 2023年8月31日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
518
试验地点
58
主要终点
Weight gain (g) from study entry to 16 weeks of study.

研究概览

简要总结

A 4 month growth monitoring study of healthy term infants fed iron fortified infant formula. Infants will be fed ad-libitum for 16 weeks and growth will be evaluated in terms of weight gain over the 16 weeks.

详细描述

A Growth Monitoring Study conducted according to FDA established guidelines to evaluate the test infant formulas ability to promote normal growth and development.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

Study infant formulas have been blinded

入排标准

年龄范围
1 Day 至 14 Days(Child)
性别
All
接受健康志愿者

入选标准

  • Healthy Term Infant

排除标准

  • Any health condition that would negatively impact infant feeding and growth.

结局指标

主要结局

Weight gain (g) from study entry to 16 weeks of study.

时间窗: 16 weeks of Clinical Study

Growth Monitoring Study

次要结局

  • Recumbent length gain (cm) from study entry to 16 weeks of study.(16 weeks of Clinical Study)
  • Tolerance of study formulas over 16 weeks of study(16 weeks of Clinical Study)
  • Head Circumference gain (cm) from study entry to 16 weeks of study(16 weeks of Clinical Study)

研究者

发起方
Aussie Bubs, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (58)

Loading locations...

相似试验